xylazine has been researched along with Heart Diseases in 1 studies
Xylazine: An adrenergic alpha-2 agonist used as a sedative, analgesic and centrally acting muscle relaxant in VETERINARY MEDICINE.
xylazine : A methyl benzene that is 1,3-dimethylbenzene which is substituted by a 5,6-dihydro-4H-1,3-thiazin-2-ylnitrilo group at position 2. It is an alpha2 adrenergic receptor agonist and frequently used in veterinary medicine as an emetic and sedative with analgesic and muscle relaxant properties.
Heart Diseases: Pathological conditions involving the HEART including its structural and functional abnormalities.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sterba, M | 1 |
| Simůnek, T | 1 |
| Popelová, O | 1 |
| Potácová, A | 1 |
| Adamcová, M | 1 |
| Mazurová, Y | 1 |
| Holecková, M | 1 |
| Gersl, V | 1 |
1 other study available for xylazine and Heart Diseases
| Article | Year |
|---|---|
Early detection of anthracycline cardiotoxicity in a rabbit model: left ventricle filling pattern versus troponin T determination.
Topics: Anesthetics; Animals; Antibiotics, Antineoplastic; Biomarkers; Blood Pressure; Calcium; Collagen; Da | 2007 |